Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

U.S. News & World Report children’s hospitals cardiology heart surgery

The top 10 children’s hospitals for cardiology and heart surgery

The 2022-2023 rankings include some familiar names at the top. Did your facility make the cut? 

COPD patients benefit from TAVR—but there are some significant risks to consider

When discussing the possibility of TAVR for a patient with COPD, it is crucial to consider the severity of their symptoms.  

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Corvia Medical raises $54M to continue studying implantable heart failure treatment

The company will use the funds to follow up on what it learned from the REDUCE LAP-HF II clinical trial.

New insights into what causes cardiac hypertrophy—and how to treat it

“We have finally been able to pinpoint one of the key reasons why the heart muscle wall thickens," one researcher said. 

Thumbnail

Seeing the future: How routine eye exams could predict heart attacks

Researchers presented their findings at the 2022 European Human Genetics Conference in Vienna. 

Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology.

'Promising' new data on TMVr among cancer patients

The study's authors examined data from nearly 23,000 patients who underwent transcatheter mitral valve repair from 2014 to 2018. 

Thumbnail

TAVR vs. surgery among children and young adults with congenital heart disease

Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on. 

Medtronic is once again recalling its HeartWare Ventricular Assist Device (HVAD) pump implant kit, a part of the company’s HeartWare HVAD system. This is a Class I recall, which means using the device can lead to serious injury or death. The new recall includes more than 1,600 devices distributed from October 2006 to June 2021.

FDA announces another recall of Medtronic HVAD pump implant kits—1 patient death reported

The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.